A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13–20 weeks gestation
Authors:
Open Access
- 5 May 2005
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 20 (8) , 2348-2354
Abstract
BACKGROUND: Several studies have now reported the successful use of the sublingual administration of misoprostol for medical abortion in the first trimester. The objective of this study was to assess the acceptability to women, the efficacy of the regimen, as well as the acceptability to staff of sublingual versus vaginal administration of misoprostol following mifepristone for medical abortion at 13–20 weeks gestation. METHODS: Women were randomized by opening consecutive sealed envelopes generated using random number tables. Mifepristone (200 mg) was followed 36–48 h later by sublingual administration of misoprostol 600 μg or vaginal misoprostol 800 μg. This was followed by 3 hourly doses of misoprostol 400 μg administered sublingually or vaginally. RESULTS: A total of 76 women were randomized. Of women in the sublingual group, 24 (66.7%) expressed satisfaction with the route of misoprostol administration compared with 25 (62.5%) in the vaginal group. A higher proportion in the sublingual group used intramuscular opiates. There was no significant difference in the surgical evacuation rate between the sublingual (three out of 36 women, 8.3%) and vaginal groups (one out of 40, 2.5%), (P=0.26) and acceptability to staff was the same for both methods. CONCLUSIONS: Sublingual administration of misoprostol following mifepristone is an acceptable and effective alternative to vaginal administration for medical abortion at 13–20 weeks gestation. However, women should be advised about the greater likelihood of requiring stronger analgesia.Keywords
This publication has 23 references indexed in Scilit:
- Effects of misoprostol on uterine contractility following different routes of administrationHuman Reproduction, 2004
- Midtrimester medical termination of pregnancy: a review of 1002 consecutive casesContraception, 2004
- A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancyBJOG: An International Journal of Obstetrics & Gynaecology, 2002
- A comparison of medical induction and dilation and evacuation for second-trimester abortionAmerican Journal of Obstetrics and Gynecology, 2002
- A randomized comparison of medical abortion and surgical vacuum aspiration at 10-13 weeks gestationHuman Reproduction, 2002
- Nonsurgical mid‐trimester termination of pregnancy: a review of 500 consecutive casesBJOG: An International Journal of Obstetrics & Gynaecology, 1999
- Induction of Abortion with Mifepristone (RU 486) and Oral or Vaginal MisoprostolNew England Journal of Medicine, 1995
- Pregnacny: The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486)Human Reproduction, 1993
- Pain of first-trimester abortion: a study of psychosocial and medical predictorsPain, 1989
- Routine intraoperative ultrasonography for second trimester abortion reduces incidence of uterine perforation.Journal of Ultrasound in Medicine, 1989